Therapeutic Goods (Prescription Medicines—Sharing of AusPARs) (Information) Specification 2023 (Cth)

Therapeutic Goods (Prescription Medicines—Sharing of AusPARs) (Information) Specification 2023

I, Nicholas Henderson, as delegate of the Minister for Health and Aged Care, make the following specification.

Dated 20 July 2023

Nicholas Henderson Acting First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health and Aged Care

Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Release of therapeutic goods information 6 Repeals Schedule 1—Therapeutic goods information Schedule 2—Repeals Therapeutic Goods Information (Sharing of Information about Prescription Medicines) Specification 2015

1 Name This instrument is the Therapeutic Goods (Prescription Medicines—Sharing of AusPARs) (Information) Specification 2023.

2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument The day after this instrument is registered.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority This instrument is made under subsection 61(5AB) of the Therapeutic Goods Act 1989.

4 Definitions Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following: (a) health practitioner; (b) medicine; (c) product information; (d) Register; (e) registered goods; (f) Secretary. In this instrument: Act means the Therapeutic Goods Act 1989. approved product information means the product information approved by the Secretary under section 25AA of the Act. AusPAR means the Australian Public Assessment Report for a prescription medicine, including the attached approved product information, that is published by the TGA. Note: AusPARs may also include the Clinical Evaluation Report, or an extract of the Clinical Evaluation Report, as an attachment. AusPARs are published on the TGA website at www.tga.gov.au. Australian Prescriber means the journal published by Therapeutic Guidelines. registered prescription medicine means a medicine that: (a) is included in the part of the Register for goods known as registered goods; and (b) would require a prescription from a health practitioner who is authorised to prescribe medicine under a law of a State or Territory. Therapeutic Goods Administration, or TGA, means the part of the Department known as the Therapeutic Goods Administration. therapeutic goods information has the meaning given by subsection 61(1) of the Act. Therapeutic Guidelines means Therapeutic Guidelines Ltd (ABN 45 074 766 224).